BMJ – A New Vision for Mental Health

Undisclosed financial conflicts of interest in DSM-5-TR: cross sectional analysis

Author: Editorial 12th January 2024 0 Comments

This study has been published in the British Medical Journal. The abstract says: “Objective: To assess the extent and types of financial ties to industry of panel and task force members of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders,…
Read more

a coherent system

BMJ, British Medical Journal, conflict of interest, Diagnostic & Statistical Manual (DSM), DSM, Research

The influence of paid opinion leaders on the prescribing of antidepressants in the UK

Author: Editorial 8th January 2024 0 Comments

A former NHS psychiatrist has submitted two rapid responses to the BMJ (British Medical Journal) in relation to this published letter : Reversing the rate of antidepressant prescribing. The first response begins: “I see that there have been a number of responses to this letter: Reversing the rate…
Read more

a coherent system

antidepressants, BMJ, British Medical Journal, depression, Hole Ousia, prescribing

The government has a moral duty to help those harmed by prescribed dependence forming drugs

Author: Editorial 22nd June 2023 0 Comments

This “ open letter by healthcare professionals ” calls for specialist NHS services to support patients harmed by taking prescription medications. Published in the British Medical Journal, the letter begins: “This week, BBC1’s Panorama drew sharp attention to the problem of prescribed drug dependence and…
Read more

a coherent system

antidepressants, BBC Panorama, benzodiazepines, BMJ, British Medical Journal, drug dependency, drug withdrawal, National Institute for Health and Care Excellence, pharmaceutical industry, psychiatry, Public Health England

From FDA to MHRA: are drug regulators for hire?

Author: Editorial 7th July 2022 0 Comments

This article by Maryanne Demasi has been published in the British Medical Journal: “Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies…
Read more

a coherent system

BMJ, British Medical Journal., drug regulators, Food & Drug Administration (FDA), Maryanne Demasi, Medicines and Healthcare Products Regulatory Agency, MHRA, pharmaceutical industry

The trouble with antidepressants: why the evidence overplays benefits and underplays risks

Author: Editorial 18th September 2020 0 Comments

“Widespread prescribing has not reduced mental disability or suicide, raising questions about the assessment of evidence on effectiveness and safety of antidepressants” This essay by John B. Warren has been published the British Medical Journal (BMJ). It begins: “Depression can be…
Read more

collaborative practice

antidepressants, BMJ, British Medical Journal, depression, efficacy of antidepressants, John B. Warren, safety of antidepressants